European Healthtech startup funding raised during January 2025.
In January 2025, 35 European Healthtech companies raised a combined €1.5B across 35 funding rounds, up 248.7% versus January 2024. UK led by capital raised, and Novo Holdings was the most active investor. Data as of 9 Jul 2026.
2 exits.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Verdiva Bio | Series A | Jan 2025 | €399M |
| Neko Health | Series B | Jan 2025 | €250M |
| Cera | Other | Jan 2025 | €150M |
| CeQur | Other | Jan 2025 |
| €116M |
| Fire1 | Other | Jan 2025 | €115M |
| Orbis Medicines | Series A | Jan 2025 | €90M |
| Leyden Labs | Other | Jan 2025 | €68M |
| Numab | Series C | Jan 2025 | €53M |
| Quibim | Series A | Jan 2025 | €50M |
| Coave Therapeutics | Series A | Jan 2025 | €32M |
| Deciphex | Series C | Jan 2025 | €31M |
| Robeaute | Series A | Jan 2025 | €27M |
| Arctic Therapeutics | Series A | Jan 2025 | €27M |
| Eupry | Series A | Jan 2025 | €23M |
| Oxcan | Series A | Jan 2025 | €11M |
